KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 54 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $7,508,000 | -61.3% | 712,968 | 0.0% | 0.34% | -57.5% |
| Q2 2015 | $19,400,000 | -10.4% | 712,968 | +0.8% | 0.81% | -1.6% |
| Q1 2015 | $21,649,000 | +9.1% | 707,268 | +33.5% | 0.82% | -7.6% |
| Q4 2014 | $19,835,000 | +16.2% | 529,920 | +8.5% | 0.89% | +24.0% |
| Q3 2014 | $17,063,000 | +36.5% | 488,342 | +81.9% | 0.72% | +35.5% |
| Q2 2014 | $12,501,000 | +1458.7% | 268,540 | +667.3% | 0.53% | +1414.3% |
| Q4 2013 | $802,000 | – | 35,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |